• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA launches medical device innovation challenge to combat opioid crisis

May 30, 2018 By Chris Newmarker

FDAThe U.S. FDA today announced that it has launched an innovation challenge to encourage the development of medical devices to help reduce the country’s opioid abuse crisis.

The hope is that the challenge will result in new medtech including digital health technologies and diagnostic tests to help detect, treat and prevent addiction, according to FDA.

Go to FDA’s website to find out more about submitting applications for the challenge.

Companies selected by the FDA under the new program will work closely with the agency, with accelerated development and review of their products. In addition, FDA will grant breakthrough device designation to those devices that meet the statutory criteria for designation, without the companies having to submit a separate application.

“Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in tackling the opioid crisis. We must advance new ways to find tools to help address the human and financial toll of opioid addiction,” Dr. Scott Gottlieb, FDA’s commissioner, said in a news release.

The roots of the prescription opioid overdose crisis in America go back to the late 1990s, when pharmaceutical companies touted prescription painkillers that weren’t supposed to be addictive but actually were. Medical professionals more frequently prescribed opioid painkillers, and opioid-related deaths steadily increased. Tens of thousands of people have been dying annually, according to the Centers for Disease Control and Prevention.

Gottlieb noted that medical devices that can effectively address local pain syndromes could, in some cases, even supplant use opioids to treat pain — reducing the need for the potentially addictive drugs.

“We’re hopeful that in collaborating with public health-minded innovators, we can identify and accelerate the development of new technologies — whether a device, diagnostic test, mobile medical app or even new clinical decision support software — that can contribute in novel and effective ways to help reduce the scope of this crisis,” Gottlieb said.

The challenge is open to products in any stage of development, from concept to testing, as well as developers of currently marketed devices who want to demonstrate an improved benefit-risk profile for their devices.

FDA is accepting submissions from June 1 through Sept. 30, and plans to announce selected applicants in November after evaluation by a team at FDA’s Center for Devices and Radiological Health.

FDA in recent years has already cleared, granted or approved more than 200 devices to help treat or manage pain; 10 of them involved new or novel technologies including brain and spinal cord stimulators to relieve pain. FDA also recently granted a new indication to an electric stimulation device that could help reduce the symptoms of opioid withdrawal.

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Implants, Neurological, Technology Tagged With: FDA, opioid epidemic

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS